Revibe Health writes the clearest description of what compounded medication actually is that we have found anywhere in this category. It also promises your money back with “no ifs, no buts” without telling you how much money that is, over a window that expires before the medication reaches a dose designed to do anything.
A Guarantee With No Price Attached
The promise is unusually emphatic: if you are dissatisfied, or you do not see major changes within 30 days, “you can ask for your money back and you will be refunded in full. No ifs. No buts.”
No price appears anywhere on the site. Not for medication, not for consultations, not for labs. A refund guarantee is a promise about a sum of money, and Revibe has not disclosed the sum.
That inversion is worth naming plainly, because a guarantee is doing a specific job in a purchase decision — it is meant to cap your downside. You cannot assess a cap without knowing the exposure. A full refund on $200 and a full refund on $2,000 are very different offers, and the marketing leans hardest on the promise precisely where the number is absent.
The absolute language is also qualified elsewhere on the same site: “Must medically qualify. Terms apply. Contact Revibe for full offer details.” “Terms apply” and “no ifs, no buts” cannot both be true. The undisclosed terms are the actual policy; the slogan is the advertisement for it. Ask for the written refund terms and the price list together, and treat whichever you receive as the real offer.
Thirty Days Is the Wrong Window
Set the pricing aside and the guarantee still has a structural problem. It offers a refund if you do not see major changes within 30 days. GLP-1 medications are not dosed to produce major changes in 30 days.
Both semaglutide and tirzepatide start at a deliberately low introductory dose and escalate over months. The first four weeks are spent at a starting dose chosen for tolerability rather than efficacy — it exists to let the gut adapt, not to drive weight loss. The trial results everyone quotes come from many months at progressively higher doses: roughly 15% mean loss for semaglutide at 68 weeks, roughly 21% for tirzepatide at 72 weeks.
So a 30-day results guarantee closes at almost exactly the point where a correctly managed patient is still on the introductory dose. Judged against its own criterion, the treatment is expected to have done little — and a patient who invokes the guarantee on time is quitting before the medicine has started.
This is the risk in guarantees attached to slow-acting treatments. They read as confidence and they can function as churn: the window rewards leaving early, and anyone who stays past it has lost the protection at exactly the point where costs begin to accumulate. It also creates a quiet incentive to escalate dosing faster than tolerance would suggest, which is the opposite of good titration. Nothing indicates Revibe does that — but the guarantee structure is in tension with how these drugs are meant to be used.
The Compounding Disclosure Is Excellent
Credit where it is due, and this is significant. Revibe states that its compounded GLP-1 treatments “are not FDA-approved and are not equivalent to any FDA-approved drug”, and separately acknowledges that FDA-approved versions are available.
That second clause — not equivalent to any FDA-approved drug — is the most accurate sentence on compounding we have encountered on a seller’s own site. The common industry framing is that a compounded preparation contains “the same active ingredient” as the brand, which is true and misleading: same molecule does not mean demonstrated equivalence in purity, potency, stability or absorption, none of which has been established for a compounded copy. Most sellers gesture at this. Revibe says it outright, and it says it while trying to sell you the compounded product.
Telling a prospective customer that the thing you are selling is not equivalent to the approved alternative, and that the approved alternative exists, is the disclosure behaviour this category needs more of. Our compounded versus brand-name guide covers why that distinction carries so much weight.
The Calculator
A weight-loss calculator on the site projects, from a 232 lb starting point, “up to 46 lbs in one year” — just under 20% of body weight.
That is at the very top of what the best drug in this class achieved in a registration trial, presented as a personalised projection to someone who has entered nothing but a weight. “Up to” carries all the load: it describes the ceiling, not the middle of the distribution, and it is generated before anyone knows which medication you would be prescribed, at what dose, or whether you would tolerate it.
Provider Facts
| Medications offered | Compounded GLP-1 treatments; individual molecules are not named on the pages we reached. Hormone therapy offered alongside |
|---|---|
| Brand-name or compounded | Compounded, disclosed as not FDA-approved and not equivalent to any FDA-approved drug; approved versions acknowledged to exist |
| Consultation process | Virtual, with a free initial appointment advertised |
| Eligibility | Not published beyond a statement that patients must medically qualify |
| Provider involvement | Licensed providers; credentials described as varying by location |
| Lab requirements | Lab work offered through the same practice; panels and cost not published |
| Pharmacy fulfillment | Direct delivery from the pharmacy; pharmacy not named |
| Shipping frequency | Medication delivered by mail from the pharmacy; timings not published |
| Support services | Combined weight and hormone practice with separate men's and women's divisions |
| Membership fees | Not published |
| Medication fees | Not published |
| Cancellation policy | Not published |
| Refund policy | A 30-day money-back guarantee advertised in absolute terms, qualified elsewhere by must medically qualify and terms apply |
| Insurance | Not published |
| HSA/FSA | Not published |
| Availability | Contact forms indicate Arizona, Hawaii, Utah, Oregon, Washington, Oklahoma, Texas and California |
Pros and Cons
Pros
- The clearest compounding disclosure we have found on a seller’s own site
- Acknowledges that FDA-approved alternatives exist
- Operating since 2011 rather than a recent arrival
- Lab work available through the same practice
- Free initial appointment
- Eight states identifiable from the site
Cons
- No prices published at all, which makes the guarantee unevaluable
- “No ifs, no buts” contradicted by “terms apply” on the same site
- 30-day results window closes before titration reaches a therapeutic dose
- Individual medications are never named
- Calculator projects a near-best-case result to anyone who enters a weight
- Pharmacy not named; no insurance or HSA/FSA detail
Who It May Be Best For
Potentially suitable if you live in one of the eight states it appears to serve and you want weight and hormone care from one practice — that combination is genuinely useful and not widely offered.
Use the free appointment to get three things in writing: the monthly price, the actual written refund terms behind “terms apply”, and which molecule at what dose. The consultation costs nothing, so there is no reason to proceed without them.
Do not let the 30-day guarantee drive the decision. By design you will still be on an introductory dose when it expires, so it protects you against far less than it appears to.
Alternatives
Emerge Weight Loss publishes an all-in compounded price. Measured sells FDA-approved medication at published rates. Hone Health combines weight and hormone care with every price listed. Our best compounded GLP-1 providers page ranks this segment.
Limitations of This Review
Based on Revibe Health’s own published materials at revibehealth.com, checked on 5 September 2026. The state list is inferred from options presented in the site’s contact forms rather than from a published coverage map, and may be incomplete. Anything marked not published means we could not find it — prices and refund terms are explicitly available on request, which is why we recommend asking. Statements about GLP-1 titration schedules and trial outcomes come from the published literature, not from Revibe. Nothing here is medical advice.
Frequently Asked Questions
How much does Revibe Health cost?
Not published — no medication, consultation or lab pricing appears on the site. The initial appointment is advertised as free, so ask for a full price list then.
Is the 30-day guarantee meaningful?
Less than it sounds. Standard GLP-1 titration keeps you on a low introductory dose for roughly the first four weeks, so the window closes before the medication reaches a therapeutic dose. The absolute wording is also qualified elsewhere by “terms apply”.
Is the medication FDA-approved?
No. Revibe states its compounded GLP-1 treatments are not FDA-approved and are not equivalent to any FDA-approved drug, and notes that approved versions exist. That is an unusually accurate disclosure.
Which states does it serve?
Its contact forms point to Arizona, Hawaii, Utah, Oregon, Washington, Oklahoma, Texas and California. No formal coverage map is published, so confirm directly.
Verdict
2.7 / 5 — no pricing published
An established practice that tells the truth about compounded medication more plainly than anyone else here, wrapped in marketing that promises an unconditional refund of an undisclosed amount over a window that expires before the treatment starts working.
The point worth carrying beyond this provider: check what a guarantee’s clock is measured against. For a treatment that escalates over months, a 30-day results window is not a strong promise — it is a promise timed to expire before the promise could be tested.
Medical Disclaimer & Review Date
This review is general consumer information, not medical advice. GLP-1 medications are prescription drugs with serious contraindications, and whether any treatment is appropriate for you is a decision only a licensed healthcare provider who knows your medical history can make. Nothing here should be used to start, stop, or change a medication.
Details in this review come from Revibe Health's own published materials as of the date below. Pricing, medication availability, state coverage, and policies in this category change frequently — verify current terms directly with the provider before purchasing.
Date reviewed: September 5, 2026